Intensive care patients are deprived of enteral or parenteral nutrition. This article gives you detailed information of all your queries regarding Nutrition in ICU patients
Daily minimum nutritional requirements of the critically illRalekeOkoye
Critically ill patients have nutritional needs that are essential in their management. This is a synopsis with specific calculable applications for the daily recommended components of nutrition in critical care.
Intensive care patients are deprived of enteral or parenteral nutrition. This article gives you detailed information of all your queries regarding Nutrition in ICU patients
Daily minimum nutritional requirements of the critically illRalekeOkoye
Critically ill patients have nutritional needs that are essential in their management. This is a synopsis with specific calculable applications for the daily recommended components of nutrition in critical care.
Total enteral nutrition and total parenteral nutrition in critically ill pat...Prof. Mridul Panditrao
Prof. mridul panditrao, discusses intricate problems of starvation, the pathophysiological changes, Total enteral nutrition, total parenteral nutrition, various protocols etc...
Total enteral nutrition and total parenteral nutrition in critically ill pat...Prof. Mridul Panditrao
Prof. mridul panditrao, discusses intricate problems of starvation, the pathophysiological changes, Total enteral nutrition, total parenteral nutrition, various protocols etc...
In the changing scenario of pharmacy practice in India, for successful practice of
Hospital Pharmacy, the students are required to learn various skills like drug distribution,
drug dispensing, manufacturing of parenteral preparations, drug information, patient
counselling, and therapeutic drug monitoring for improved patient care
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
6. METABOLIC ALTERATIONS IN ICU PATIENTS
• moderate to severe hypermetabolism,
• increased gluconeogenesis with insulin
resistance,
• a large increase in endogenous lipolysis
• net loss of the lean body mass
• Cytokines
• Stress hormones
• Opoids and neurotransmitors
• Others
• Fever,
• Increase in cardiac output
• Increase in energy demand
7. THE INCREASE IN ENERGY EXPENDITURE (EE), IS DIRECTLY
RELATED TO THE EXTENT AND TYPE OF INJURY/SEPSIS
EE increases
minor or localised infections 5-15%
severe infection or multiple trauma 10-15%
uncontrolled sepsis,
Acute Respiratory Distress Syndrome (ARDS),
burn patients
More than 20%
9. NUTRITION ASSESSMENT
• The clinical assessment,
• Signs: oedema, cachexia, muscle atrophy and mucosal lesions: glossitis
• Body weight
• Biological markers
• Plasma albumin,
• transthyretin,
• transferrin,
• Measurements of body composition
• skinfold thickness
• arm muscle circumference,
• by bioelectrical impedance
• Nitrogen (N) balance
• Electrolytes
• retinol-binding protein
• fibronectin
• insulin-like growth factor-1
10. PRACTICAL ASSESSMENT OF NUTRITIONAL STATUS
• Patient history and clinical setting
• Diseases associated with increased risk of malnutrition (e.g. chronic debilitating disease)
• History of chronic low food intake, drug abuse, alcoholism, chronic psychiatric disorders
• Diseases associated with hypermetabolism and prolonged catabolic activity (e.g. polytrauma, burns, persistent fever, sepsis, multiple organ
failure)
• Clinical and anthropometric assessment
• Signs of malnutrition on physical examination (e.g. cachexia, muscle atrophy, oedema)
• Recent severe body weight loss (≥5% of usual body weight in one month or ≥ 10% in three months)
• Body mass index (body weight in kg/(height in m2)) < 18.5 kg/m2
• Biochemical parameters
• Hypoalbuminemia < 35g/L
• Plasma electrolytes levels (K, Mg, P, Ca)
• Nitrogen balance (negative) values: ≤5 g (low stress) 5 to 15 g (moderate stress) ≥15 g (severe stress)
11. NUTRITIONAL REQUIREMENTS
• indirect calorimetry: Reference method or Gold standard
• Harris-Benedict formulae
• Men: EE (kcal/day) = 66 + (13.7 x W) + (5 x H) - (6.8 x A)
• Women: EE (kcal/day) = 655 + (9.6 x W) + (1.7 x H) - (4.7 x A)
• W = weight in kg, H = height in cm, A = age in years.
• Faisy equation: In ventilated critically ill patients
• In practice,
• 25-35 (20-30 non-protein) kcal/kg/
• 10% for every degree of body temperature >37˚ C.
• protein intake 1.2 and 1.5 g/kg/day,
• not exceed 2.0 g/kg/day
• except in losses (e.g.
• extensive burns,
• GI and/or urinary losses,
12. WHEN TO GIVE NUTRITIONAL THERAPY
• Any critically ill patient in whom oral intake is not expected to cover the full
energy needs in the first three days following ICU admission
Pragmatic indications
• Severe stress in patients unable to eat for 5-7
days or more
• Severe trauma and burns
• After small bowel resection
• Resumption of gastrointestinal tract activity
and preparation for oral feeding
Evidence-based indications
• Well-nourished patients including
patients with prolonged fasting or
insufficient oral intake.
• Pre-existing malnutrition,, in a patient
unable to cover their full energy needs
by oral intake.
•
13. ROUTE OF ENTERAL NUTRITION
ENTERAL NUTRITION (EN)
• first-line nutritional support
• nasogastric or nasojejunal tube,
• or through percutaneous
• gastrostomy
• jejunostomy
PARENTERAL NUTRITION (PN)
• if EN is not feasible
• Total PN: in CVC (>900 mosm/l)
• Peripheral PN: in peripheral line (≤900 mosm/l)
COMBINED EN AND PN
• If EN is difficult to fully optimise in the first three days following ICU admission in
malnourished patients
14. ADVANTAGES OF EN AND PN
ENTERAL NUTRITION (EN)
• Favours intestinal villous integrity and function,
• Promotes gut motility,
• Maintains GI tract immune functions
• Reduces bacterial translocation from the gut
• Avoids infectious complications associated with parenteral
nutrition
• Reduces the risk of metabolic complications with PN:
hyperglycaemia, insulin resistance, hypertriglyceridemia, fatty
liver
• Less costly
PARENTERAL NUTRITION (PN)
• Easy to perform
• Ensures full delivery of specific nutritional needs
• Avoids risks of
• gastrooesophageal reflux,
• aspiration pneumonia,
• enteral-feeding associated diarrhoea and GI intolerance
(vomiting,...)
15. CONTRAINDICATION FOR EN
ABSOLUTE
• Adequate oral intakes (>80% of the energy
target)
•• Generalised peritonitis
Non-functional gut: anastomotic disruption,
lower GI obstruction, gut ischaemia/necrosis
• Uncontrolled severe shock states
RELATIVE
• Expected period of fast ≤5 days, except in severely injured
patients
• Abdominal distension/severe protracted diarrhoea
• Localised peritonitis, intra-abdominal abscess, active upper GI
tract haemorrhage
• Coma with risk of aspiration (especially gastric feeding)
• Very short bowel (less than 70 cm) or high output fistulae
• Electrolytes or fluid or substrate intolerance (kidney, heart, liver
failure)
• Terminal disease
• Dementia, agitation, confusion
16. CONTRAINDICATION FOR PN
ABSOLUTE
• Adequate oral intake
• Enteral nutrition feasible and
covering > 60% of the energy target
within 3 days
• Uncontrolled severe shock states
RELATIVE
• Absence of central venous access (
• Electrolyte or fluid or substrate intolerance (kidney,
heart, liver failure)
• Incompatibility between intravenous drugs and
parenteral nutrition solution in the absence of multiple
port catheters
• Dementia, agitation, confusion
17.
18.
19. MONITORING AND COMPLICATIONS
EN
• Tube misplacement and bronchial
aspiration
• Gastrointestinal dysfunction
• High residual volume
• Abdominal cramps, nausea, vomiting
and diarrhoea
PN
• Catheter-related sepsis (CRS)
• Non-septic complications:
• air embolism,
• injury to thoracic structures
• Metabolic complications
• Hyperglycaemia
• hypertyglcidemia
• Hypoglycaemia
• cardiac arrhythmias,
• Catheter thrombosis
• Liver abnormalities
• Pancreatic disorders